Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2, Randomized, Open-Label, Dose Titration, Efficacy and Safety Study of FG-4592 (Roxadustat) in Non-Dialysis Chronic Kidney Disease Patients With Anemia

NCT01244763 is registered in ClinicalTrials.gov with Kyntra Bio as lead sponsor.

NCT NCT01244763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01244763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2, Randomized, Open-Label, Dose Titration, Efficacy and Safety Study of FG-4592 (Roxadustat) in Non-Dialysis Chronic Kidney Disease Patients With Anemia
Lead sponsor
Kyntra Bio
Phase
Phase 2
Overall status
Completed
Start date
October 29, 2010
Completion date
June 13, 2012
Enrollment
145 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, chronic kidney disease